Do you want to receive the latest myeloma news and research for free, directly in your email inbox? You can with the Myeloma Minute!

Subscribe below to receive weekly email newsletters with up-to-the 'minute' information about multiple myeloma. The Myeloma Minute includes:

  • blogs and videos from Dr. Brian G.M. Durie,
  • inspirational videos,
  • information about drug recalls,
  • research announcements,
  • patient support events,
  • regional educational outreach,
  • advocacy action, and more.
Stay in Touch for the Latest Information
For late breaking news and events, subscribe to the Myeloma Minute!
The October 12, 2018 issue covers how dogs are a potential medical ally, the IMF gearing up for ASH 2017, and a Nurse Leadership Board webinar on shared decision making.
The October 11, 2018 issue covers new multiple myeloma imaging guidelines, nutrition, side effect management, and more.
The October 4, 2018 issue covers the FDA's authorization of marketing of ClonoSEQ assay, a next-generation sequencing (NGS) test used for assessing minimal residual disease (MRD) in multiple myeloma patients.
The September 27, 2018 issue covers “The Impact of Nutrition on Side Effect Management," a Regional Community Workshop, a Patient & Family seminar, and more.
This September 20, 2018 issue covers the IMF and Amgen's efforts for Blood Cancer Awareness Month, webinars, and more.

Do you want to receive the latest myeloma news and research for free, directly in your email inbox? You can with the Myeloma Minute!

Subscribe below to receive weekly email newsletters with up-to-the 'minute' information about multiple myeloma. The Myeloma Minute includes:

  • blogs and videos from Dr. Brian G.M. Durie
  • inspirational videos 
  • information about drug recalls
  • latest multiple myeloma research announcements
  • patient support events
  • regional educational outreach
  • advocacy actions

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.